IL188759A0 - Pyrazole derivatives as therapeutic agents - Google Patents
Pyrazole derivatives as therapeutic agentsInfo
- Publication number
- IL188759A0 IL188759A0 IL188759A IL18875908A IL188759A0 IL 188759 A0 IL188759 A0 IL 188759A0 IL 188759 A IL188759 A IL 188759A IL 18875908 A IL18875908 A IL 18875908A IL 188759 A0 IL188759 A0 IL 188759A0
- Authority
- IL
- Israel
- Prior art keywords
- therapeutic agents
- pyrazole derivatives
- pyrazole
- derivatives
- therapeutic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0516661.6A GB0516661D0 (en) | 2005-08-13 | 2005-08-13 | Therapeutic agents |
| PCT/GB2006/002990 WO2007020388A1 (en) | 2005-08-13 | 2006-08-09 | Pyrazole derivatives as therapeutic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL188759A0 true IL188759A0 (en) | 2008-08-07 |
Family
ID=35098275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL188759A IL188759A0 (en) | 2005-08-13 | 2008-01-14 | Pyrazole derivatives as therapeutic agents |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1915364A1 (en) |
| JP (1) | JP2009504717A (en) |
| KR (1) | KR20080039939A (en) |
| CN (1) | CN101282963A (en) |
| AR (1) | AR055368A1 (en) |
| AU (1) | AU2006281300A1 (en) |
| BR (1) | BRPI0614626A2 (en) |
| CA (1) | CA2619228A1 (en) |
| EC (1) | ECSP088250A (en) |
| GB (1) | GB0516661D0 (en) |
| IL (1) | IL188759A0 (en) |
| MX (1) | MX2008002065A (en) |
| NO (1) | NO20080372L (en) |
| RU (1) | RU2008108179A (en) |
| TW (1) | TW200728300A (en) |
| UY (1) | UY29741A1 (en) |
| WO (1) | WO2007020388A1 (en) |
| ZA (1) | ZA200800698B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102008015032A1 (en) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituted pyrazolamides and their use |
| DE102008015033A1 (en) | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituted (pyrazolyl-carbonyl) imidazolidinones and their use |
| DE102008062863A1 (en) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituted (thiophenyl-carbonyl) imidazolidinones and their use |
| DE102008062878A1 (en) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituted furancarboxamides and their use |
| DE102009036604A1 (en) | 2009-07-30 | 2011-02-03 | Aicuris Gmbh & Co. Kg | Substituted bis-arylpyrazolamides with terminal primary amide functionality and their use |
| DE102011055815A1 (en) | 2011-11-29 | 2013-05-29 | Aicuris Gmbh & Co. Kg | Carboxamide-substituted heteroaryl-pyrazoles and their use |
| DE102012016908A1 (en) | 2012-08-17 | 2014-02-20 | Aicuris Gmbh & Co. Kg | Tris (hetero) aryl-pyrazoles and their use |
| CN105061227A (en) * | 2015-07-27 | 2015-11-18 | 广东先强药业有限公司 | Environment-friendly ritodrine hydrochloride production method |
| WO2020123855A1 (en) | 2018-12-12 | 2020-06-18 | University Of Washington | Inhibitor compounds for male contraception |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4419078B2 (en) * | 2002-12-02 | 2010-02-24 | アステラス製薬株式会社 | Pyrazole derivative |
| US7247628B2 (en) * | 2002-12-12 | 2007-07-24 | Pfizer, Inc. | Cannabinoid receptor ligands and uses thereof |
| ES2329915T3 (en) * | 2004-02-20 | 2009-12-02 | Astrazeneca Ab | DERIVATIVES OF 1,5-DIFENYLPIRAZOL 3-USEFUL SUBSTITUTES AS CB1 MODULATORS |
-
2005
- 2005-08-13 GB GBGB0516661.6A patent/GB0516661D0/en not_active Ceased
-
2006
- 2006-08-01 TW TW095128062A patent/TW200728300A/en unknown
- 2006-08-08 AR ARP060103449A patent/AR055368A1/en unknown
- 2006-08-09 CA CA002619228A patent/CA2619228A1/en not_active Abandoned
- 2006-08-09 KR KR1020087004570A patent/KR20080039939A/en not_active Application Discontinuation
- 2006-08-09 RU RU2008108179/04A patent/RU2008108179A/en not_active Application Discontinuation
- 2006-08-09 MX MX2008002065A patent/MX2008002065A/en not_active Application Discontinuation
- 2006-08-09 CN CNA2006800374501A patent/CN101282963A/en active Pending
- 2006-08-09 EP EP06779114A patent/EP1915364A1/en not_active Withdrawn
- 2006-08-09 BR BRPI0614626-0A patent/BRPI0614626A2/en not_active Application Discontinuation
- 2006-08-09 AU AU2006281300A patent/AU2006281300A1/en not_active Abandoned
- 2006-08-09 JP JP2008526536A patent/JP2009504717A/en active Pending
- 2006-08-09 WO PCT/GB2006/002990 patent/WO2007020388A1/en active Application Filing
- 2006-08-11 UY UY29741A patent/UY29741A1/en not_active Application Discontinuation
-
2008
- 2008-01-14 IL IL188759A patent/IL188759A0/en unknown
- 2008-01-21 NO NO20080372A patent/NO20080372L/en not_active Application Discontinuation
- 2008-01-23 ZA ZA200800698A patent/ZA200800698B/en unknown
- 2008-03-07 EC EC2008008250A patent/ECSP088250A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB0516661D0 (en) | 2005-09-21 |
| KR20080039939A (en) | 2008-05-07 |
| ZA200800698B (en) | 2009-01-28 |
| AR055368A1 (en) | 2007-08-22 |
| CA2619228A1 (en) | 2007-02-22 |
| RU2008108179A (en) | 2009-09-20 |
| MX2008002065A (en) | 2008-04-16 |
| AU2006281300A1 (en) | 2007-02-22 |
| TW200728300A (en) | 2007-08-01 |
| BRPI0614626A2 (en) | 2012-12-04 |
| ECSP088250A (en) | 2008-04-28 |
| WO2007020388A1 (en) | 2007-02-22 |
| JP2009504717A (en) | 2009-02-05 |
| UY29741A1 (en) | 2007-03-30 |
| CN101282963A (en) | 2008-10-08 |
| NO20080372L (en) | 2008-04-16 |
| EP1915364A1 (en) | 2008-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1962961A4 (en) | Demibodies: dimerisation-activated therapeutic agents | |
| IL191907A0 (en) | Azepinoindole derivatives as pharmaceutical agents | |
| GB0506147D0 (en) | Therapeutic agents | |
| EP1730148A4 (en) | Aminobenzoxazoles as therapeutic agents | |
| GB0609492D0 (en) | Therapeutic agents | |
| GB0608928D0 (en) | Therapeutic agents | |
| GB0601962D0 (en) | Therapeutic agents | |
| GB0521139D0 (en) | Therapeutic agent | |
| IL180044A0 (en) | Pyrazole derivatives | |
| GB0519797D0 (en) | Therapeutic agents | |
| GB0615545D0 (en) | Therapeutic agent | |
| GB0505437D0 (en) | Therapeutic agents | |
| GB0505725D0 (en) | Therapeutic agents | |
| GB0616214D0 (en) | Therapeutic Agents | |
| GB0519350D0 (en) | Therapeutic agents | |
| GB0518819D0 (en) | Therapeutic agents | |
| ZA200800698B (en) | Pyrazole derivatives as therapeutic agents | |
| GB0518817D0 (en) | Therapeutic agents | |
| GB0611152D0 (en) | Therapeutic agents | |
| GB0514738D0 (en) | Therapeutic agents | |
| GB0620818D0 (en) | Therapeutic agents | |
| IL180889A0 (en) | Pyrazole derivative | |
| GB0620059D0 (en) | Therapeutic agents | |
| GB0609676D0 (en) | Therapeutic agents | |
| GB0523998D0 (en) | Therapeutic agents |